2024年6月最新影响因子数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎
反馈给我们。基本信息 | 登录收藏 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | Frontiers in Pharmacology FRONT PHARMACOL (此期刊被最新的JCR期刊SCIE收录) LetPub评分 7.8
101人评分
我要评分
声誉 8.1 影响力 7.2 速度 8.4 | |||||||||||||||||||||
期刊ISSN | 1663-9812 | 微信扫码收藏此期刊 | ||||||||||||||||||||
2023-2024最新影响因子 (数据来源于搜索引擎) | 4.4 点击查看影响因子趋势图 | |||||||||||||||||||||
实时影响因子 | 截止2024年3月26日:4.278 | |||||||||||||||||||||
2023-2024自引率 | 4.50%点击查看自引率趋势图 | |||||||||||||||||||||
五年影响因子 | 5 | |||||||||||||||||||||
JCI期刊引文指标 | 1.15 | |||||||||||||||||||||
h-index | 62 | |||||||||||||||||||||
CiteScore ( 2024年最新版) |
| |||||||||||||||||||||
期刊简介 |
| |||||||||||||||||||||
期刊官方网站 | http://journal.frontiersin.org/journal/pharmacology | |||||||||||||||||||||
期刊投稿网址 | http://www.frontiersin.org/submission/submissioninfo.aspx | |||||||||||||||||||||
期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足Frontiers in Pharmacology的语言要求,还能让Frontiers in Pharmacology编辑和审稿人得到更好的审稿体验,让稿件最大限度地被Frontiers in Pharmacology编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评(3篇) 论文致谢(22篇) 。
提交文稿 | |||||||||||||||||||||
是否OA开放访问 | Yes | |||||||||||||||||||||
OA期刊相关信息 | 文章处理费:需要( USD3295; ) 文章处理费豁免:查看说明 其他费用:没有 期刊主题关键词:pharmacology、pharmaceutics、ethnopharmacology、experimental pharmacology、neuropharmacology 相关链接:Aims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | |||||||||||||||||||||
通讯方式 | AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, SWITZERLAND, CH-1015 | |||||||||||||||||||||
出版商 | Frontiers Media S.A. | |||||||||||||||||||||
涉及的研究方向 | PHARMACOLOGY & PHARMACY- | |||||||||||||||||||||
出版国家或地区 | SWITZERLAND | |||||||||||||||||||||
出版语言 | English | |||||||||||||||||||||
出版周期 | ||||||||||||||||||||||
出版年份 | 0 | |||||||||||||||||||||
年文章数 | 2944点击查看年文章数趋势图 | |||||||||||||||||||||
Gold OA文章占比 | 99.61% | |||||||||||||||||||||
研究类文章占比: 文章 ÷(文章 + 综述) | 70.07% | |||||||||||||||||||||
WOS期刊SCI分区 ( 2023-2024年最新版) | WOS分区等级:1区
| |||||||||||||||||||||
中国科学院《国际期刊预警 名单(试行)》名单 | 2024年02月发布的2024版:不在预警名单中 2023年01月发布的2023版:不在预警名单中 2021年12月发布的2021版:不在预警名单中 2020年12月发布的2020版:不在预警名单中 | |||||||||||||||||||||
中国科学院SCI期刊分区 ( 2023年12月最新升级版) | 点击查看中国科学院SCI期刊分区趋势图
| |||||||||||||||||||||
中国科学院SCI期刊分区 ( 2022年12月升级版) |
| |||||||||||||||||||||
中国科学院SCI期刊分区 ( 2021年12月旧的升级版) |
| |||||||||||||||||||||
SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE) Scopus (CiteScore) Directory of Open Access Journals (DOAJ) | |||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1663-9812%5BISSN%5D | |||||||||||||||||||||
平均审稿速度 | 网友分享经验: 14 Weeks | |||||||||||||||||||||
平均录用比例 | 网友分享经验: | |||||||||||||||||||||
版面费/APC文章处理费信息 | 文章处理费:需要( USD3295; ) 文章处理费豁免:查看说明 其他费用:没有 LetPub提供文章处理费(APC)支持服务,可以用人民币支付版面费啦! | |||||||||||||||||||||
LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)后论文在Frontiers in Pharmacology顺利发表。
快看看作者怎么说吧:服务好评 论文致谢 | |||||||||||||||||||||
期刊常用信息链接 |
|
|
|
中国学者近期发表的论文 | |
1. | Integrative bioinformatics approaches to establish potential prognostic immune-related genes signature and drugs in the non-small cell lung cancer microenvironment Author: Zhou, Jiao; Shi, Shan; Qiu, Yeqing; Jin, Zhongwen; Yu, Wenyan; Xie, Rongzhi; Zhang, Hongyu Journal: FRONTIERS IN PHARMACOLOGY. 2023; Vol. 14, Issue , pp. -. DOI: 10.3389/fphar.2023.1153565 PubMed DOI |
2. | Comprehensive analysis of the cuproptosis-related gene DLD across cancers: A potential prognostic and immunotherapeutic target Author: Yang, Weiguang; Guo, Qiang; Wu, Haiyang; Tong, Linjian; Xiao, Jian; Wang, Yulin; Liu, Rui; Xu, Lixia; Yan, Hua; Sun, Zhiming Journal: FRONTIERS IN PHARMACOLOGY. 2023; Vol. 14, Issue , pp. -. DOI: 10.3389/fphar.2023.1111462 PubMed DOI |
3. | Potential therapeutic effects of Chinese meteria medica in mitigating drug-induced acute kidney injury Author: Li, Jun; Li, Tonglu; Li, Zongping; Song, Zhiyong; Gong, Xuezhong Journal: FRONTIERS IN PHARMACOLOGY. 2023; Vol. 14, Issue , pp. -. DOI: 10.3389/fphar.2023.1153297 PubMed DOI |
4. | Geniposide plus chlorogenic acid reverses non-alcoholic steatohepatitis via regulation of gut microbiota and bile acid signaling in a mouse model in vivo Author: Li, Hongshan; Xi, Yingfei; Xin, Xin; Feng, Qin; Hu, Yiyang Journal: FRONTIERS IN PHARMACOLOGY. 2023; Vol. 14, Issue , pp. -. DOI: 10.3389/fphar.2023.1148737 PubMed DOI |
5. | Myelin sheath injury and repairment after subarachnoid hemorrhage Author: Chen, Mao; Guo, Peiwen; Ru, Xufang; Chen, Yujie; Zuo, Shilun; Feng, Hua Journal: FRONTIERS IN PHARMACOLOGY. 2023; Vol. 14, Issue , pp. -. DOI: 10.3389/fphar.2023.1145605 PubMed DOI |
6. | Polyphyllin I suppresses the gastric cancer growth by promoting cancer cell ferroptosis Author: Zheng, Fang; Wang, Yeshu; Zhang, Qunfang; Chen, Qiuyuan; Liang, Chun-Ling; Liu, Huazhen; Qiu, Feifei; Chen, Yuchao; Huang, Haiding; Lu, Weihui; Dai, Zhenhua Journal: FRONTIERS IN PHARMACOLOGY. 2023; Vol. 14, Issue , pp. -. DOI: 10.3389/fphar.2023.1145407 PubMed DOI |
7. | Immune cell death-related lncRNA signature as a predictive factor of clinical outcomes and immune checkpoints in gastric cancer Author: Zhang, Zeyu; Su, Duntao; Thakur, Abhimanyu; Zhang, Kui; Xia, Fada; Yan, Yuanliang Journal: FRONTIERS IN PHARMACOLOGY. 2023; Vol. 14, Issue , pp. -. DOI: 10.3389/fphar.2023.1162995 PubMed DOI |
8. | Metabolomics-based discovery of XHP as a CYP3A4 inhibitor against pancreatic cancer Author: Yang, Yuting; Guo, Yanlei; Luo, Hua; Wang, Menglei; Chen, Fang; Cui, Huawei; Chen, Ping; Yin, Zhujun; Li, Li; Dai, Ying; Zeng, Jin; Zhao, Junning Journal: FRONTIERS IN PHARMACOLOGY. 2023; Vol. 14, Issue , pp. -. DOI: 10.3389/fphar.2023.1164827 PubMed DOI |
9. | Zanthoxylum bungeanum seed oil inhibits tumorigenesis of human melanoma A375 by regulating CDC25A/CyclinB1/CDK1 signaling pathways in vitro and in vivo Author: Wang, Wanting; Pang, Wenwen; Yan, Suying; Zheng, Xiaoli; Han, Qiurong; Yao, Yao; Jin, Leixin; Zhang, Chunze Journal: FRONTIERS IN PHARMACOLOGY. 2023; Vol. 14, Issue , pp. -. DOI: 10.3389/fphar.2023.1165584 PubMed DOI |
10. | Low-dose of caffeine alleviates high altitude pulmonary edema via regulating mitochondrial quality control process in AT1 cells Author: Tian, Liuyang; Jia, Zhilong; Yan, Yan; Jia, Qian; Shi, Wenjie; Cui, Saijia; Chen, Huining; Han, Yang; Zhao, Xiaojing; He, Kunlun Journal: FRONTIERS IN PHARMACOLOGY. 2023; Vol. 14, Issue , pp. -. DOI: 10.3389/fphar.2023.1155414 PubMed DOI |
|
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2024 中国: LetPub上海 网站备案号:沪ICP备10217908号-1 沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)
增值电信业务经营许可证:沪B2-20211595 网络文化经营许可证:沪网文[2023]2004-152号
礼翰商务信息咨询(上海)有限公司 办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室